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Abstract
A nonintegrating mutant, SIVsmD116N, was derived from the infectious pathogenic SIVsmE543-3 clone by introducing an Asp (D) to Asn
(N) mutation into the catalytic domain of integrase. Although SIVsmD116N generated all viral proteins following transfection, cell-free virus did
not productively infect CEMx174 cells, macaque peripheral blood mononuclear cells (PBMCs) or monocyte-derived macrophages (MDM). Viral
DNA and transcripts were observed transiently in SIVsmD116N-infected CEMx174 cells and macaque PBMC but persisted in MDM for as long
as 20 days. Circular forms of viral DNAwere detected but there was no evidence of integration detected by Alu PCR. We found that SIV D116N
mutant remained transcriptionally active and expressed low levels of viral proteins persistently in MDM. These data are consistent with a role for
macrophages as a persistent latent reservoir for AIDS viruses. The capacity of nonintegrating SIV to persistently generate viral products in
macrophages suggests that nonintegrating lentiviral vectors could be engineered to efficiently and safely express proteins for vaccine purposes.
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As retroviruses, human immunodeficiency virus (HIV) and
simian immunodeficiency virus (SIV) must accomplish sequential
events to achieve successful infection. Following viral entry and
reverse transcription, the newly synthesized viral DNA integrates
into the host chromatin (Bukrinsky et al., 1992). Integration is
mandatory for viral production, but HIV/SIV infection in vivo
results in high levels of nonintegratedDNA (Wu, 2004). Priorwork
has demonstrated transient expression of both early and late mes-
sage by nonintegrated HIV DNA in CD4 T cells (Stevenson et al.,
1990; Wiskerchen and Muesing, 1995). The transcription from
nonintegrated DNA is a normal and early step in HIV replication.
Nonintegrated DNA has the capacity to synthesize all classes of
viral transcripts, early, multiply spliced, late, singly spliced, and
non-spliced transcripts, prior to integration (Wu andMarsh, 2003a).
The capacity of pre-integration HIV DNA to transcribe is of in-
terest, since about half of the reverse-transcribed DNA from HIV
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doi:10.1016/j.virol.2007.11.002shows that about 45% ofHIVDNA is not integrated (Zennou et al.,
2000), but the biological relevance and possible pathogenic role of
nonintegrated viral DNA is not clear (Wu and Marsh, 2003b). The
nonintegrated viral DNA has been shown to carry transcriptional
activity in human CD4 Tcells and it can direct limited syntheses of
viral early proteins such as Nef. It has been demonstrated that Nef
synthesized from nonintegrated DNA can promote T cell activity
and down regulate CD4 molecules (Gillim-Ross et al., 2005b).
These observations prompted us to evaluate SIV viral gene expres-
sion in non-dividing macaque macrophages infected with a no-
nintegrated mutant SIV virus. In this study, we constructed a
nonintegrated mutant, SIVsmD116N (D116N), and evaluated its
ability to replicate, transcribe and express viral proteins following
infection of macrophages in vitro.
Results
Nonintegrating SIV mutant and reverse transcriptase assay for
its infectivity
In previous research, HIV-1IN/D116N mutant was derived by
introducing an Asp (D) to Asn (N) mutation within the integrase
Fig. 1. SIVsmD116N virus can generate all the viral proteins at the same level as
WT SIVsmE543. The SIVsmD116N and WT SIVsmE543 clones were trans-
fected into 293T cells to generate cell-free viruses. Viruses were concentrated
and Western blotting was performed to analyze the viral proteins. The proteins
shown here are gp120, p66, p55, gp41, gp31, p27 (from top to bottom).
Fig. 2. Nonintegrated mutant virus SIVsmD116N does not replicate in host cells.
Reverse transcriptase assay was carried out to evaluate infectivity of the WTand
SIVsmD116N mutant in CEMx174 cells (A), macaque PBMC (B) and macaque
MDM (C). TheWT virus replicated well in CEMx174 cells, macaque PBMCs as
well as in MDM. In contrast, no RT activity was observed in cell-free media
following infection with the integrase mutant SIVsmD116N in any of these cell
types.
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to completely abolish viral DNA integration of HIV without
affecting other known viral functions such as reverse trans-
cription and nuclear targeting (Engelman et al., 1995). In this
study, we constructed a nonintegrating mutant of SIV, using
the infectious molecular clone, SIVsmE543-3 as a parent.
SIVsmE543-3, derived from a biological isolate obtained late
in disease from an immunodeficient rhesus macaque (E543)
with SIV-induced encephalitis (Hirsch et al., 1997) replicated
efficiently in macaque peripheral blood mononuclear cells
(PBMCs) and monocyte-derived macrophages (MDM) in vitro
and induced AIDS when inoculated intravenously into ma-
caques (Dehghani et al., 2003; Hirsch et al., 1997, 2004).
The nonintegrating mutant, SIVsmD116N, was derived from
SIVsmE543-3 by a “G” to “A” substitution at site 4877,
resulting in an Asp (D) to Asn (N) substitution into the inte-
grase catalytic domain. The wild-type (WT) and mutant plas-
mids were transfected to 293T cells and produced comparable
levels of cell-free reverse transcriptase activity (data not
shown). Western blot analysis of cell-free virus supernatants
revealed a similar pattern of viral proteins (Fig. 1). This sug-
gests that the SIVsmD116N mutation had no effect on viral
protein synthesis, processing and assembly. Infectivity of the
WT and SIVsmD116N mutant was evaluated in CEMx174
cells, macaque PBMC and macaque MDM using equivalent
virus inoculum size based on RT activity. As expected, the WT
virus replicated well in CEMx174 cells, macaque PBMCs as
well as in MDM (Figs. 2A, B, and C). In contrast, no RTactivity
was observed in cell-free media following infection with the
integrase mutant SIVsmD116N in any of these cell types
(Fig. 2). This was consistent with previous findings demon-strating an essential role for integration in HIV/SIV infection
(Englund et al., 1995).
Persistence of nonintegrated viral DNA in macrophages
Since previous studies of HIVD116N demonstrated persis-
tence and expression in resting T cells, we chose to focus on
macrophages, another non-dividing target of HIV/SIV. PCR
was used to investigate whether SIVsmD116N was capable of
Table 1
Sequences of used primers
Primer Sequence Position a
Subclone-1 5′-GGTATTACCTCAAGGGTGGAAGGG-3′ 3295–3318
Subclone-2 5′-TCGGCAGGTGATTTACTGCTG-3′ 5918–5938
Mutagenic-1 5′-CCATCACACATCTGCATACTAATAATGGTGCCAATTTCACAT-3′
Mutagenic-2 5′-ATGTGAAATTGGCACCATTATTAGTATGCAGATGT GTGATGG-3′
SIV/DNA-5′ 5′-CCGAACAGGGACTTGAAGG AGGTGA-3′ 708–731
SIV/DNA-3′ 5′-TTTGTTCCTGCCGCCCTTACTG-3′ 894–915
SIV/Circle-5′ 5′-GCAAGTGTGTGTTCCCATCTCTCC-3′ 9310–9331
SIV/Circle-3′ 5′-AGCTCTCCGTCGTGGTTTGTTC-3′ 909–930
Alu1-1 5′-TAGTCGGGAGGCTGAGGCAGGAGAA-3′ 172–196 (Human Alu)
Alu1-2 5′-GTCATCCCACTGATGAGTCTGTGC-3′ 207–230 (LTR U3)
Alu2-1 5′-TGGAAGGGATTTATTACAATGAGAAAAGAC-3′ 1–30
Alu2-2 5′-CTCGTCTTCCTGGGCTTCATCT-3′ 164–185
SIV/5′ 5′-CCGAACAGGGACTTGAAGGAGGTGA-3′ 842–866
SIV/nef-tat-rev 5′-CTCTGGAGCACTGGTTGGAGGATCTG-3′ 9011–9036
SIV/3′ env 5′-GCAAGAGCGCGATAAGCA GCTGATTC-3′ 6616–6641
SIV/3′ vif 5′-CTGCTGCAAGTCCACCATGCCC ATC-3′ 5485–5509
SIV/3′ gagpol 5′-CTGAACCTGTCGGAACTAATGGAGC-3′ 1257–1281
a They are referred to positions in SIVsmE543 sequence except Alu1-1 and mutagenic primers.
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ges (MDM) in vitro. Total cellular DNA from WT and
SIVsmD116N-infected macrophages was isolated at different
times post-infection and PCR amplified with primers specific for
SIV late DNA, 1-LTR-circle and 2-LTR-circle DNA. Production
of SIV full-length DNA was indicated by the detection of an
LTR product using SIV/DNA-5 and SIV/DNA-3 primers (see
Table 1). Circular viral DNA forms were also detected usingFig. 3. Persistence of unintegrated viral DNA in macrophages. (A) Total cellular D
infection and PCR amplified. The nonintegrated DNA persisted for 20 days and the vi
virus. (B) Two of the nonintegrated viral DNA forms, both the 1-LTR circle and 2-LT
were much more abundant than 2-LTR circles. The D116N-infected cells had higher
amplified from each sample to ensure equal amount of cellular DNAwas used. (C) U
compare with WT- or D116N-infected cells.SIV/Circle-5′ primer and SIV/Circle-3′ primer. Based on the
detection of full-length viral DNA, the SIVsmD116N mutant
was able to synthesize viral DNA inMDMwith equal efficiency
to the WT virus. Viral DNA synthesized from SIVsmD116N
persisted for 20 days (the termination of culture) at a level
comparable with the WT virus (Fig. 3A). In addition, 1-LTR
circles and 2-LTR circles were found to be present and persisted
in both WT and SIVsmD116N infections, and 1-LTR circlesNA from WT and D116N-infected cells was extracted at different times post-
ral DNA synthesized from SIVsmD116N was at a comparable level with the WT
R circle were found to be present and persist with viral infection. 1-LTR circles
levels of 2-LTR circles than the wild-type infection. Cellular actin DNAwas co-
ninfected cells and heat-inactivated virus-infected cells were used as control to
Fig. 4. The SIVsmD116N mutant does not integrate into cell chromosome.
CEMx174 cells and macaque macrophages were infected with SIVsmE543 and
SIVsmD116N viruses. Total cellular DNA harvested was subjected to Alu-PCR
amplification. (A) No integrated viral DNA was amplified in up to 25×104
CEMx174 T cells infected with integrase mutant SIVsmD116N, while
integrated DNA was amplified well in just 1×103 CEMx174 T cells infected
with SIVsmE543. (B) In D116N-infected macrophages, Alu-PCR demonstrated
that no integrated viral DNA persisted for 20 days until the termination of the
cell culture. While in WT-infected macrophages, integrated DNA amplified well
from day 1 to day 20. For the “Alu-” controls without first round PCR, no
product was amplified.
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assay was not quantitative, the SIVsmD116N-infected cells
appeared to have significantly higher levels of 2-LTR circles
than the WT-infected cells (Fig. 3B). This result is consistent
with previous research in HIV-1 nonintegrating mutant (Wis-
kerchen and Muesing, 1995). To confirm that the PCR pro-
ducts came from SIV viral DNA rather than residual plasmid
DNA, we used cells infected with heat inactivated (56 °C for
60 min) as a control. As shown in Fig. 3C, no products were
detected in PCR reactions for SIV DNA or LTR circles from
cells infectedwith heat-inactivated virus at 2 days post-infection,
whereas these products were readily detected in the untreated
virus infection. These results indicated that the viral DNA de-
tected by PCR came from replicating virus rather than resi-
dual plasmid DNA from the transfection.
SIVsmD116N did not integrate into genomic DNA in either
T cells or macrophages
To determine whether SIVsmD116N was capable of in-
tegration into the host genome, we used an Alu sequence-based
PCR strategy (Zhuge et al., 2001). The Alu sequence is a
ubiquitous repeat element found in the human/monkey genome
but absent in the HIV/SIV genomes which can be used to
specifically demonstrate whether viral DNA is integrated into
the host chromosome. As expected, DNA was amplified fromas few as 103 CEMx174 cells infected with SIVsmE543-3,
consistent with the presence of proviral DNA in these cells
(185-bp product). In contrast, no product was detected in up to
2.5×104 CEMx174 T cells infected with SIVsmD116N virus
(Fig. 4A). Similarly, no integrated viral DNA was observed
in SIVsmD116N-infected macrophages, while in WT-infected
macrophages, integrated viral DNA persisted until the termi-
nation of the cell culture at 20 days (Fig. 4B). These results
suggested that SIVsmD116N is not capable of integration into
genomic DNA in either T cells or macrophages.
Persistence of transcriptional activity from nonintegrated viral
DNA in macrophages
To determine transcriptional activity of nonintegrated viral
DNA in macrophages, total cellular RNA was isolated and
amplified by semi-quantitative RT-PCR at different times post-
infection (Wu and Marsh, 2001). Briefly, reverse transcription of
cellular RNA was accomplished with random decamers as the
first-strand primers. Following cDNA synthesis, PCRwas carried
out using primers to detect the specific messages of SIVusing the
primers detailed in Table 1. Primer combinations used the same
forward primer, SIV/5′ and four different reverse primers, SIV/
nef-tat-rev, SIV/3′env, SIV/3′vif and SIV/3′gag-pol to detect
multiply, singly and unspliced messages. For relative quantifica-
tion of RT-PCR, cellular β-actin transcripts (294 bp) were co-
amplified using QuantumRNA β-actin Internal Standards
(Ambion, Austin, TX), with a ratio of 3/7 for actin primer/
competitor. The PCR results were compared between WT and
SIVsmD116N based upon the reference of co-amplified cellular
β-actin transcripts. Consistent with the persistence of noninte-
grated DNA, the viral transcription in SIVsmD116N-infected
macrophages was also persistent. In contrast to the transient
presence of viral DNA and its transcripts in T cells (Wu and
Marsh, 2003b), the nonintegrated viral DNA in macrophages
remained transcriptionally active until the termination of the
cultures at 20 days. However, RNA expression levels of the
SIVsmD116N mutant were much lower than that of WT virus.
As shown in Fig. 5A, PCR amplification with primers specific
for different viral transcripts demonstrated that Nef, Tat and
Env were the predominant transcripts in SIVsmD116N infec-
tion. Expression level of the Rev transcript was very low and Vif
message also declined over time in SIVsmD116N-infected mac-
rophages. To make sure the RT-PCR products came from SIV
viral gene expression, we used uninfected cells and heat-in-
activated virus infected cells as controls. As shown in Fig. 5B,
these controls were negative in contrast to amplification from
cells infected with untreated virus. These results indicated that
the viral gene expression detected by RT-PCR came from viruses
instead of any residual DNA plasmid.
Protein synthesis from SIVsmE543 and SIVsmD116N viruses in
macrophages
The capacity of nonintegrated viral DNA to direct viral pro-
tein synthesis in infected macrophages was examined by Wes-
tern blot analysis of cell lysates. Macrophages were cultured
Fig. 5. Persistence of transcriptional activity from nonintegrated viral DNA in macrophages. (A) Total cellular mRNA fromWT- or D116N-infected macrophages was
purified and amplified with RT-PCR. Multiple viral transcripts including all classes of viral splicing isoforms were detected. The nonintegrated viral DNA in
macrophages remained transcriptionally active for 20 days. RNA expression level of nonintegrated D116N mutant was much lower than that of wild type. PCR
products from RT-PCR were shown in the figure using primers specific for Tat/Rev/Nef, Env, Gag-pol, and Vif (from top to bottom). Nef, Tat and Env were the
predominant transcripts in D116N infection. Expression level of Rev transcript was very low and Vif diminished in D116N-infected macrophages over time. The PCR
results were compared between WT and SIVsmD116N based upon the reference of co-amplified cellular β-actin transcripts. (B) To confirm that the RT-PCR products
were the result of SIV viral gene expression, we add uninfected cells and heat-inactivated virus-infected cells as controls. No SIV transcripts were amplified from
uninfected cells or heat-inactivated virus-infected cells. The appropriate transcripts were detected in WT and D116N-infected cells, but not in uninfected cells or cells
infected with heat-inactivated virus.
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SIVsmD116N, and uninfected. Cells were harvested at diffe-
rent times and total cellular proteins were extracted and resol-
ved in 4–12% Bis–Tris gel (Invitrogen, Carlsbad, CA) for
Western blot detection of viral proteins using plasma from a SIV-
infected rhesus macaque E544 as a primary antibody. As shown
in Fig. 6A, viral proteins including gp160, gp120, p66, p55,
gp41, p31, p27 were strongly and persistently expressed in WT-
infected macrophages from day 1 to day 18. In contrast, the
expression level of viral proteins was much lower in D116N-
infected cells. However, some of the viral proteins were expres-
sed including, Pol-p66, Gag-p55, and Nef-p31. In order to con-
firm Gag expression in D116N-infected macrophages, SIV
polyclonal anti-p27 antibody generated in rabbit was used for
Western blotting. As shown in Fig. 6B, p27 was detected in bothD116N- and WT-infected cells at day 3 and 5 post-infection,
but the expression level in D116N was much lower than that in
WT infection. No p27 protein was detected in heat-inactiva-
ted D116N- or WT-infected cells and uninfected cells. This re-
sult confirmed de novo, low-level expression of p27 (Gag) in
D116N-infected macrophages.
Discussion
In this study, using cultured macaque macrophages as an
in vitro model, we demonstrated that nonintegrated viral DNA
can transcribe persistently in infected macrophages. In contrast
to the transient presence of nonintegrated viral DNA in T cells,
the nonintegrated SIV DNA was found to have a remarka-
ble capacity to persist and remain transcriptionally active in
Fig. 6. Proteins synthesis from SIVsmE543 and SIVsmD116N viruses in macrophages detected by Western blotting. (A) Macrophages were cultured and divided into
3 groups, infected with SIVsmE543 or SIVsmD116N, and uninfected cells. Cells were harvested at different times and Western blot was performed using plasma from
a SIV-infected rhesus macaque E544 as primary antibody. In WT-infected cells, viral proteins including gp160, gp120, p66, p55, gp41, p31 and p27 were strongly and
persistently expressed from day 1 to day 18. In D116N-infected cells, expression of viral p66, p55, p31 proteins was also observed, although the expression levels were
much lower than those in wild-type infection. The proteins also expressed persistently for 18 days in D116N-infected cells. (B) Macrophages were infected with WT
SIVsmE543, SIVsmD116N, heat-inactivated WT, or heat-inactivated D116N viruses and harvested at days 3 and 5 for Western blotting with a SIVanti-p27 antibody.
P27 was detected in both D116N and WT-infected cells at days 3 and 5 post-infection, with much higher levels in the WT infection.
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persisted for 20 days, with minimal decay of the transcriptio-
nal activity. Additionally, some viral proteins were found to be
synthesized and persisted in infected macrophages. These data
suggested that nonintegrated viral DNA could support long-
term, low-level viral protein production in non-divided macro-
phages with the potential as a therapeutic vaccine.
The nature of the transcribing, nonintegrated HIV/SIV DNA
in macrophages has not yet been determined. Nonintegrated
DNA has three different forms: linear, 1-LTR-circle, and 2-LTR-
circle DNA (Pauza and Galindo, 1989). Previous studies
showed that HIV 2-LTR circles are rapidly lost in dividing cell
populations, such as primary CD4+ T lymphocytes (Pauza et al.,
1994). Recent work demonstrated that 2-LTR circles persist
out up to 21 days post-infection in macrophages, a non-divi-
ding target of HIV-1 (Gillim-Ross et al., 2005a). 2-LTR circles
have been detected in the PBMCs of HIV-1-infected patients
on suppressive therapy (Cara et al., 2002; Sharkey et al., 2000).They may also persist in non-dividing cells of PBMC such as
the resting memory CD4+ T lymphocytes (Chun et al., 2000).
Extrachromosomal circular DNA in non-dividing cells such as
macrophages could be a source of persistent viral protein ex-
pression. Also, the macrophage population utilized in our
study served as a model of a primary non-dividing cell po-
pulation, nonintegrated HIV/SIV may persist in other non-
dividing cell populations such as memory CD4+ T lympho-
cytes (Chun and Fauci, 1999; Chun et al., 1997). Persistent
transcription ability of nonintegrated SIV DNA in non-dividing
cells may have unknown functions and be important for SIV
pathogenesis.
Previous research on D116N mutant HIV-1 in CD4+ T cells
demonstrated transient expression of both early and late mes-
sages by nonintegrated HIV DNA. However, only the early
multiply spliced transcripts were measurably translated (Wu and
Marsh, 2003a). The selective expression of early proteins from
unintegrated HIV-1 templates has been hypothesized to result
297Y. Zheng et al. / Virology 372 (2008) 291–299from low levels of Rev expression (Wu and Marsh, 2003a).
During the late phase of infection, Rev promotes nuclear export
and enables the cytoplasmic expression of single spliced and
unspliced transcripts and therefore the translation of structural
proteins. In contrast with these findings with HIV-1 integrase
mutants, we observed persistent low-level synthesis of both
early and structural proteins from nonintegrated SIV DNA in
macrophages. The transcription profile of the SIV D116N mu-
tant was consistent with the hypothesis that low levels of Rev
were responsible for the low-level expression of structural
proteins. In addition, low-level expression of structural pro-
teins of SIVsmD116N could be due to the difference in target
cells used in the two studies (T cells versus macrophages) or to
a difference in the amount of SIV Rev required for structural
protein synthesis as compared to HIV. However, the HIV and
SIV D116N mutants are similar in all other respects including
the lack of detectable virus production. Our SIV mutant also
expressed diminishing levels of the Vif transcript. The major
cell types for infection, CD4 T cells and macrophages, are
restrictive for HIV/SIV replication and require Vif for main-
taining viral infectivity (Goncalves et al., 1996). Thus the Vif
protein of HIV is required during late stages of viral produc-
tion to counter the antiviral activity of APOBEC3G, a protein
expressed notably in human T lymphocytes. When produced
in the presence of APOBEC3G, vif-defective virus is non-
infectious (Mangeat et al., 2003).
An effective vaccine is urgently needed to stop the con-
tinuing spread of HIV worldwide. However, the development
of an AIDS vaccine is proving to be an unprecedented chal-
lenge (Nabel, 2002). The lack of functional virus-specific
effector T lymphocytes and neutralizing antibodies is a key
immunogical feature of chronic HIV and SIV infections (Singh
et al., 2005). The path to an HIV vaccine has been fraught with
difficulties mainly because of the virulent nature of the virus
and its ability to thwart the immune system over time (Letvin
and Walker, 2003). Clearly an integrase mutant such as used in
the present study did not express viral proteins efficiently as
required for an immunogen and would have an inherent risk of
reversion. However, the capacity of a nonintegrating SIV to
persistently generate viral proteins in macrophages implies that
nonintegrating lentiviral vectors could be engineered to more
efficiently express proteins for use as a therapeutic vaccine,
without the permanency of an integrated retrovirus or disruption
of normal cellular genes.
Materials and methods
Construction of nonintegrating mutant of SIVsmD116N clone
The SIVsmE543-3 DNA sequence was changed from
“GAT” to “AAT”, by substitution of “G” at site 4877 with
“A” using the QuikChange site-directed mutagenesis kit (Stra-
tagene, La Jolla, CA). Initially we derived a 2644-nt subclone
of SIVsmE543 by PCR with Subclone-1 and Subclone-2 pri-
mers (Table 1) using the Top10 cloning kit (Invitrogen, Carls-
bad, CA) and QuikChange PCR used to derive subSIVD116N
according to the manufactures protocols. Mutagenic-1 andmutagenic-2 primers (Table 1) were designed according to
Stratagene primer design software. SubSIVsmD116N and
SIVsmE543 were digested by BstE II/BstB I, and the 2561-bp
fragment with the correct mutation was ligated into the 12Kb
SIVsmE543 vector to construct the SIVsmD116N plasmid. The
SIVsmD116N plasmid was sequenced to confirm that it con-
tained only the desired mutation.
Viruses, cells, and replication assay
The SIVsmD116N and WT SIVsmE543-3 clones were
transfected into 293T cells to generate cell-free viruses using
FuGENE transfection reagent (Roche, Indianapolis, IN) accord-
ing to the manufacturer's instructions. Cell-free virus superna-
tants used for subsequent infections were treated with DNase I
(Invitrogen, Carlsbad, CA) at 25 °C for 10 min to remove con-
taminating plasmid DNA. CEMx174 T cells, PBMC, and MDM
were infected with cell-free supernatant normalized for p27
antigen content from 293T cells transfected with SIVsmD116N
or SIVsmE543 viruses (a multiplicity of infection 0.2). Cells
were incubated with virus for 2–3 h, then pelleted and resus-
pended in fresh culture medium. Virus replication was detected
by 32P reverse transcriptase (RT) assay as previously reported
(Sears et al., 1999). For experiment control, SIVsmD116N or
SIVsmE543 viruses were heated on 56 °C for 60 min to be
inactivated and then were used to infect cells.
Culturing of monocyte-derived macrophages (MDMs)
To obtain MDMs, PBMCs were separated from whole
blood by Percoll density centrifugation and were cultured in
48-well plates in RPMI 1640 medium (Life Technologies,
Rockville, MD) containing 15% heat-inactivated fetal bovine
serum (FBS, Hyclone, Logan, Utah), 10% human type AB
serum (Sigma, St. Louis, MO) and 500 U/ml macrophage
colony-stimulating factor (M-CSF, R&D systems, Minneapo-
lis, MN) for 5 days. Cells were washed 3–5 times with pre-
warmed RPMI 1640 medium to remove non-adherent cells.
Adherent cells were maintained in fresh RPMI 1640 medium
containing 15% heat-inactivated FBS, 5% human type AB
serum and 200 U/ml M-CSF for 2 days, after which they were
infected with viruses.
DNA and RNA isolation and detection
Total cellular DNA and RNA were purified using SV total
RNA isolation kit (Promega, Madison, WI, USA), as recom-
mended by the manufacturer. The primer sequences used to
detect viral RNA andDNA are listed in Table 1. For the detection
of full-length viral DNA by PCR, forward SIV/DNA-5 primer
and anti-sense SIV/DNA-3 primer were used. PCR was carried
out in 1× Ambion PCR buffer, 125 μM dNTP, 50 pmol each
primer, 1U SuperTaq Plus (Ambion, Austin, TX) with 30 cycles
of 94 °C for 20 s, 60 °C for 30 s, 68 °C for 40 s. Both the 1-long
terminal repeat (LTR) circles and 2-LTR circles, SIV/Circle-5′
primer and SIV/Circle-3′ primer were used for detection of
circular viral DNA forms. For the detection of viral RNA species,
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random decamers as the first-strand primers. Following cDNA
synthesis, PCR was performed using SIV/5′ primer and SIV/nef-
tat-rev primer to amplify doubly spliced viral transcripts Nef, Tat
and Rev. For relative quantification of RT-PCR, cellular β-actin
transcripts were co-amplified using QuantumRNA β-actin Inter-
nal Standards (Ambion, Austin, TX), with a ratio of 3/7 for actin
primer/competitor. For analysis of singly spliced viral transcripts
such as the Env transcript, SIV/5′ primer and SIV/3′ env primer
were used, whereas for the Vif transcript, SIV/5′ primer and SIV/3′
vif primer were used. For analysis of Gag-Pol transcript, SIV/5′
primer and SIV/3′ gag-pol primer were used.
Assay for integration
To detect SIV integration into the host genome, we used an
Alu sequence-based PCR strategy to amplify the junction bet-
ween the nearest Alu sequence and the SIV LTR. Nested PCR
was used for Alu-PCR, with Alu 1-1 primer corresponding to
human Alu sequence position 172–196, and Alu 1-2 primer
located in the U3 region (bp 230–207) of SIV LTR (Zhuge
et al., 2001). Following the first round of Alu-PCR, a second
round of PCR was carried out by using a 1:500 dilution of the
first round PCR product as a template and the LTR-specific
primers Alu 2-1 and Alu 2-2 (Table 1). The amplification
conditions for Alu-PCR were 35 cycles of 94 °C for 20 s, 65 °C
for 30 s, 68 °C for 40 s. To ensure that the second round PCR
products were derived from first round PCR product (integrated
DNA) rather than nonintegrated DNA carry-over, a 1:500
dilution of the original DNA samples was used as templates
for second round PCR as a negative control.
Immunodetection of viral protein
Western blotting was performed for detecting viral protein
expression. Samples were run on 4–12% Bis–Tris gel (In-
vitrogen, Carlsbad, CA) and transferred to 0.2-μm nitrocellu-
lose membrane in a NovexMini-Cell unit (Invitrogen, Carlsbad,
CA) as suggested by the manufacturer. For Fig. 1 and Fig. 6A,
anti-SIV antiserum from SIVsmF236-infected rhesus E544
was used as a primary antibody. This antiserum reacts with the
Env, Gag, Pol and Nef proteins of SIV. A 1:1000 dilution of
primary antibody was incubated with the membrane over-
night, followed by 3 washes. The membrane was then in-
cubated with a secondary 1:10,000 diluted sheep anti-human Ig
whole antibody conjugated with horseradish peroxidase (HRP,
Amersham, Piscataway, NJ) for 1 h. Proteins on membrane
were detected by ECL plus Western blotting detection rea-
gents (Amersham, Piscataway, NJ). MagicMark™ XP Western
Protein Standard (Invitrogen, Carlsbad, CA) was used as mar-
ker. SIVanti-p27 antibody was a gift from Dr. Raoul Benveniste
in NCI, NIH. It is a polyclonal antibody generated in rabbit
immunized with p27 protein of SIVmneE11S virus. The SIV
anti-p27 antibody was used as primary antibody for the Wes-
tern blotting shown in Fig. 6B, and anti-rabbit IgG whole
antibody conjugated with horseradish peroxidase (HRP, Amer-
sham, Piscataway, NJ) was used as secondary antibody.Acknowledgments
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